The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

NCT01393509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Solid Tumor
Lymphoma
Myeloproliferative Neoplasms (MPN)

Interventions

DRUG: PU-H71

Sponsor

Memorial Sloan Kettering Cancer Center